D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
SK Telecom
SKM
$12.1B
| $6.91M | ﹤0.01% |
319,807
+186,829
| +140% | +$4.14M |
|
1852
Zevra Therapeutics
ZVRA
$562M
| $6.9M | ﹤0.01% |
725,830
+536,517
| +283% | +$5.38M |
|
1853
Pathward Financial
CASH
$1.86B
| $6.88M | ﹤0.01% |
93,003
+34,050
| +58% | +$2.65M |
|
1854
Rayonier
RYN
$6.55B
| $6.88M | ﹤0.01% |
271,984
+72,305
| +36% | +$1.73M |
|
1855
CALL
Kinder Morgan
KMI
$71.7B
| $6.88M | ﹤0.01% |
243,000
+98,100
| +68% | +$2.69M |
|
|
PACH
1856
Pioneer Acquisition I Corp
PACH
| $6.88M | ﹤0.01% |
+691,682
| New | +$6.89M |
|
1857
Blackstone Mortgage Trust
BXMT
$2.45B
| $6.87M | ﹤0.01% |
372,995
-137,743
| -27% | -$2.66M |
|
1858
Canadian Solar
CSIQ
$1.02B
| $6.86M | ﹤0.01% |
526,179
-80,300
| -13% | -$960K |
|
|
HYAC
1859
DELISTED
Haymaker Acquisition Corp 4
HYAC
| $6.85M | ﹤0.01% |
603,700
| – | – |
|
1860
Delek US
DK
$4.16B
| $6.84M | ﹤0.01% |
211,983
+190,395
| +882% | +$4.97M |
|
1861
Gold Royalty Corp
GROY
$600M
| $6.84M | ﹤0.01% |
1,772,140
+291,786
| +20% | +$901K |
|
|
SVC
1862
Service Properties Trust
SVC
$1.04B
| $6.83M | ﹤0.01% |
503,711
+96,292
| +24% | +$1.3M |
|
1863
XP
XP
$8.81B
| $6.82M | ﹤0.01% |
363,195
-136,322
| -27% | -$2.44M |
|
1864
NexGen Energy
NXE
$6.06B
| $6.82M | ﹤0.01% |
762,106
+565,104
| +287% | +$4.17M |
|
1865
Morningstar
MORN
$7.22B
| $6.82M | ﹤0.01% |
29,379
+6,464
| +28% | +$1.72M |
|
1866
CALL
First Horizon
FHN
$12.2B
| $6.78M | ﹤0.01% |
+300,000
| New | +$6.67M |
|
1867
PUT
Group 1 Automotive
GPI
$3.41B
| $6.78M | ﹤0.01% |
15,500
+6,300
| +68% | +$2.83M |
|
|
WENN
1868
Wen Acquisition Corp
WENN
$388M
| $6.77M | ﹤0.01% |
+668,767
| New | +$6.82M |
|
1869
ResMed
RMD
$30.6B
| $6.77M | ﹤0.01% |
24,716
-3,061
| -11% | -$836K |
|
1870
PUT
Transmedics
TMDX
$2.64B
| $6.73M | ﹤0.01% |
+60,000
| New | +$7.02M |
|
1871
Cracker Barrel
CBRL
$1.26B
| $6.72M | ﹤0.01% |
152,590
+574
| +0.4% | +$33.2K |
|
1872
RBC Bearings
RBC
$17.4B
| $6.72M | ﹤0.01% |
17,209
+16,012
| +1,338% | +$6.23M |
|
1873
CALL
Generac Holdings
GNRC
$11.6B
| $6.7M | ﹤0.01% |
40,000
+38,500
| +2,567% | +$6.75M |
|
1874
Bruker
BRKR
$9.57B
| $6.69M | ﹤0.01% |
+205,917
| New | +$7.34M |
|
1875
Celldex Therapeutics
CLDX
$2.99B
| $6.66M | ﹤0.01% |
257,332
-388,325
| -60% | -$9M |
|
Similar funds
D.E. Shaw & Co's Q3 2025 Portfolio in Review
As of Q3 2025, D.E. Shaw & Co held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- D.E. Shaw & Co's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- D.E. Shaw & Co added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- D.E. Shaw & Co's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- D.E. Shaw & Co fully exited Hess in Q3 2025, selling an estimated $527M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- D.E. Shaw & Co opened 714 new positions and closed 514 in Q3 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.